In-Vitro Diagnostics Instruments Market Future Outlook: Strong Growth Expected Toward $99.43 Billion by 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the In-Vitro Diagnostics Instruments Market in 2026, and what figure is it projected to hit by 2030?
The in-vitro diagnostics instruments market size has demonstrated robust expansion in recent years. It is projected to increase from $61.09 billion in 2025 to $67.18 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. Historically, this growth can be attributed to the rising prevalence of chronic diseases, an expansion in hospital lab infrastructure, advancements in diagnostic reagents, heightened awareness for early disease detection, and various government healthcare initiatives.
The in-vitro diagnostics instruments market is projected to experience swift expansion over the coming years. Its value is anticipated to reach $99.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. This expansion during the projection period stems from factors such as technological progress in molecular diagnostics, the rise of personalized medicine, the incorporation of AI into diagnostic processes, the development of healthcare in emerging markets, and the increasing need for diagnostic devices for home use. Key trends identified for the forecast timeframe encompass the broadening of point-of-care testing, the evolution of personalized diagnostics, the uptake of rapid molecular testing, the incorporation of remote patient monitoring, and the advent of miniaturized lab instruments.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29107&type=smp
Which Drivers Are Affecting Market Participation In The In-Vitro Diagnostics Instruments Market?
The anticipated expansion of the in vitro diagnostics instruments market is linked to the increasing occurrence of chronic and lifestyle-related diseases. These diseases encompass enduring health issues predominantly shaped by routine habits, actions, and environmental elements, such as heart disease, diabetes, obesity, and certain cancers, with their rise attributed to sedentary lifestyles and unhealthy dietary habits. Consequently, there is a growing need for in vitro diagnostics instruments solutions, as the swift spread of chronic and lifestyle-related diseases compels businesses to integrate early detection and monitoring instruments for more effective disease management. For example, data from 2024 by the American Action Forum, a US-based non-profit, center-right think tank, highlights that chronic diseases continue to be a major public health issue in the U.S., affecting nearly 60 percent of adults with at least one condition, and 40 percent dealing with multiple conditions, with their prevalence projected to nearly double by 2050. Moreover, the market for chronic disease treatment is forecasted to reach approximately USD 38.02 billion by 2034, marking a substantial increase from USD 9.74 billion in 2025. These factors collectively confirm that the increasing occurrence of chronic and lifestyle-related diseases is a primary catalyst for the demand within the in vitro diagnostics instruments market.
What Segment Categories Are Covered In The In-Vitro Diagnostics Instruments Market?
The in-vitro diagnostics instruments market covered in this report is segmented –
1) By Product Type: Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Other Product Types
2) By Application: Infectious Diseases, Cancer, Cardiology, Nephrology, Autoimmune Diseases, Other Applications
3) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Point-Of-Care Settings, Blood Banks, Pharmaceutical And Biotechnology Companies, Other Healthcare Facilities
Subsegments:
1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers, Semi-Automated Clinical Chemistry Analyzers, Point-Of-Care Clinical Chemistry Devices
2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Systems
3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Deoxyribonucleic Acid Microarrays, Isothermal Amplification Devices
4) By Hematology: Automated Hematology Analyzers, Manual Hematology Analyzers, Hemostasis Analyzers, Coagulation Analyzers
5) By Microbiology: Microbial Identification Systems, Antibiotic Susceptibility Testing (AST) Systems, Blood Culture Systems, Automated Microbial Analyzers.
6) By Coagulation: Coagulometers, Platelet Function Analyzers, Thromboelastography (TEG) Systems, Point-Of-Care Coagulation Devices
7) By Other Product Types: Point-Of-Care Diagnostic Devices, Miscellaneous Laboratory Instruments
What Trends Are Expected To Impact The Competitive Landscape Of The In-Vitro Diagnostics Instruments Market?
Major companies operating in the in-vitro diagnostics instruments market are focusing on developing advanced products, such as digital polymerase chain reaction (dPCR) systems, to enable highly precise and sensitive nucleic acid quantification for advanced diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic tools that precisely quantify DNA or RNA molecules by partitioning samples into thousands of individual reactions for exceptionally accurate and sensitive detection. For instance, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, expanding its digital PCR portfolio into clinical diagnostics with a strong focus on oncology testing. This system is fully integrated and automated, designed specifically for clinical testing in oncology, featuring a cartridge-based workflow that minimizes hands-on time. The QIAcuityDx includes automated analysis and reporting software, facilitating rapid and accurate detection of genetic biomarkers for cancer diagnosis and therapy monitoring without extensive operator intervention.
Which Key Market Players Are Investing In Expansion And Innovation Within The In-Vitro Diagnostics Instruments Market?
Major companies operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc
Access The Complete Report For Deeper Market Insights:
Which Region Is Expected To Experience The Fastest Growth In The In-Vitro Diagnostics Instruments Market?
North America was the largest region in the in-vitro diagnostics instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized In-Vitro Diagnostics Instruments Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29107&type=smp
Browse Through More Reports Similar to the Global In-Vitro Diagnostics Instruments Market 2026, By The Business Research Company
Intravenous Iv Hydration Therapy Global Market Report 2026
Intravenous Immunoglobulin Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-immunoglobulin-global-market-report
Intravenous Infusion Pumps Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
